Hepatocyte growth factor is elevated in obese adolescents

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 7, 2009, Pages 645-651

  Jung, Christian ^a   Fritzenwanger, Michael ^a   Fischer, Nicole ^a   Figulla, Hans R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Adolescents; BMI; Hepatocyte growth factor; Overweight; Waist circumference

Indexed keywords

C REACTIVE PROTEIN; SCATTER FACTOR;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OBESITY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; WAIST CIRCUMFERENCE;

EID: 69949121240     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.7.645     Document Type: Article

References (27)

1. Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, Gupta CE, Sheridan C, Sheridan K, Shankar SS, Steinberg HO, March KL, Considine RV. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol 2006; 291: E843-848. (Pubitemid 44484928)
2. Rehman J, Considine RV, Bovenkerk JE, Li J, Slavens CA, Jones RM, March KL. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 2003; 41: 1408-1413. (Pubitemid 36439005)
3. Swierczynski J, Korczynska J, Goyke E, Adrych K, Raczynska S, Sledzinski Z. Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty. Obes Surg 2005; 15: 803-808. (Pubitemid 40904870)
4. Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes 2005; 29: 1308-1314. (Pubitemid 41679261)
5. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006; 74: 443-477.
6. Morishita R, Aoki M, Yo Y, Ogihara T. Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease. Endocr J 2002; 49: 273-284. (Pubitemid 34832297)
7. Tuck AB, Park M, Sterns EE, Boag A, Elliott BE. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 1996; 148: 225-232. (Pubitemid 26022451)
8. Susen S, Sautiere K, Mouquet F, Cuilleret F, Chmait A, McFadden EP, Hennache B, Richard F, de Groote P, Lablanche JM, Dallongeville J, Bauters C, Jude B, Van Belle E. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. Eur Heart J 2005; 26: 2387-2395. (Pubitemid 41552967)
9. Vistoropsky Y, Trofimov S, Malkin I, Kobyliansky E, Livshits G. Genetic and environmental determinants of hepatocyte growth factor levels and their association with obesity and blood pressure. Ann Hum Biol 2008; 35: 93-103. (Pubitemid 351264503)
10. Lamblin N, Susen S, Dagorn J, Mouquet F, Jude B, Van Belle E, Bauters C, de Groote P. Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure. Am Heart J 2005; 150: 137-143. (Pubitemid 41097441)
11. Hiratsuka A, Adachi H, Fujiura Y, Yamagishi S, Hirai Y, Enomoto M, Satoh A, Hino A, Furuki K, Imaizumi T. Strong association between serum hepatocyte growth factor and metabolic syndrome. J Clin Endocrinol Metab 2005; 90: 2927-2931. (Pubitemid 40686345)
12. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
13. Wang G, Dietz WH. Economic burden of obesity in youths aged 6 to 17 years: 1979-1999. Pediatrics 2002; 109: e81.
14. Dietz WH, Robinson TN. Overweight children and adolescents. N Engl J Med 2005; 352: 2100-2109.
15. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saaddine J, Gregg EW, Williamson DF, Narayan KM. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000; 136: 664-672. (Pubitemid 30318399)
16. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geiß HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A, Hebebrand J. Perzentile für den Body-mass-Index für das Kindes-und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde 2001; 149: 807-818. (Pubitemid 32830649)
17. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol 2006; 64: 355-365.
18. Morishita R, Moriguchi A, Higaki J, Ogihara T. Hepatocyte growth factor (HGF) as a potential index of severity of hypertension. Hypertens Res 1999; 22: 161-167. (Pubitemid 29450305)
19. Nishimura M, Nakano K, Ushiyama M, Nanbu A, Ohtsuka K, Takahashi H, Yoshimura M. Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1998; 83: 195-198. (Pubitemid 28498334)
20. Yoshitomi Y, Kojima S, Umemoto T, Kubo K, Matsumoto Y, Yano M, Sugi T, Kuramochi M. Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease. J Clin Endocrinol Metab 1999; 84: 2425-2428. (Pubitemid 30670874)
21. Motone M, Katsuya T, Ishikawa K, Iwashima Y, Sugimoto K, Yamamoto K, Fu Y, Matsuo A, Ohishi M, Rakugi H, Ogihara T. Association between hepatocyte growth factor gene polymorphism and essential hypertension. Hypertens Res 2004; 27: 247-251. (Pubitemid 38594396)
22. Nakamura S, Moriguchi A, Morishita R, Aoki M, Yo Y, Hayashi S, Nakano N, Katsuya T, Nakata S, Takami S, Matsumoto K, Nakamura T, Higaki J, Ogihara T. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun 1998; 242: 238-243. (Pubitemid 28412409)
23. Jung C, Fritzenwanger M, Figulla HR. Cardiotrophin-1 in adolescents: impact of obesity and blood pressure. Hypertension 2008; 52: e6.
24. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355. (Pubitemid 40277057)
25. Galimi F, Cottone E, Vigna E, Arena N, Boccaccio C, Giordano S, Naldini L, Comoglio PM. Hepatocyte growth factor is a regulator of monocyte-macrophage function. J Immunol 2001; 166: 1241-1247. (Pubitemid 32060285)
26. Rogers PC, Meacham LR, Oeffinger KC, Henry DW, Lange BJ. Obesity in pediatric oncology. Pediatr Blood Cancer 2005; 45: 881-891.
27. Jung C, Fischer N, Fritzenwanger M, Pernow J, Brehm BR, Figulla HR. Association of waist circumference, traditional cardiovascular risk factors and stromal-derived factor-1 in adolescents. Pediatr Diabetes 2008 Dec 3 (Epub ahead of print).